Allison Pullen, CRNP

NPI: 1477915742
Total Payments
$2,144
2024 Payments
$1,162
Companies
12
Transactions
77
Medicare Patients
576
Medicare Billing
$44,457

Payment Breakdown by Category

Food & Beverage$2,144 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,144 77 100.0%

Top Paying Companies

Company Total Records Latest Year
Gilead Sciences, Inc. $788.03 34 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $368.21 14 $0 (2024)
Mallinckrodt Hospital Products Inc. $309.46 9 $0 (2024)
Madrigal Pharmaceuticals $236.02 3 $0 (2024)
ABBVIE INC. $106.18 5 $0 (2023)
Ipsen Biopharmaceuticals, Inc $83.70 3 $0 (2024)
Intercept Pharmaceuticals, Inc. $72.23 3 $0 (2024)
AstraZeneca Pharmaceuticals LP $62.97 2 $0 (2024)
Boston Scientific Corporation $44.10 1 $0 (2023)
Sandoz Inc. $31.65 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,162 37 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($260.45)
2023 $487.83 22 Gilead Sciences, Inc. ($200.21)
2022 $279.24 9 Gilead Sciences, Inc. ($152.92)
2021 $215.28 9 Gilead Sciences, Inc. ($215.28)

All Payment Transactions

77 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/16/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.77 General
Category: Gastroenterology
12/16/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.73 General
Category: Gastroenterology
12/04/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $27.72 General
Category: CRITICAL CARE
12/04/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $16.15 General
12/02/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $30.93 General
Category: Rare Disease
11/25/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $37.99 General
Category: CRITICAL CARE
11/18/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $25.33 General
Category: Rare Disease
11/14/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $37.25 General
Category: CRITICAL CARE
11/11/2024 Sandoz Inc. HYRIMOZ (Biological) Food and Beverage In-kind items and services $31.65 General
Category: Immunology
10/28/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $31.96 General
Category: CRITICAL CARE
10/23/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $29.54 General
09/25/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $31.50 General
09/16/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.16 General
Category: Gastroenterology
09/13/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $121.62 General
Category: LIVER DISEASE
09/13/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC Food and Beverage In-kind items and services $75.59 General
09/13/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $72.95 General
Category: LIVER DISEASE
09/12/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $55.85 General
09/11/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $41.45 General
Category: LIVER DISEASE
09/11/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $17.43 General
Category: Gastroenterology
08/21/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $16.16 General
08/19/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $27.44 General
Category: Rare Disease
08/08/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $24.08 General
Category: GASTROENTEROLOGY
07/03/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.60 General
Category: Gastroenterology
07/03/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $22.49 General
Category: Gastroenterology
07/02/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $31.27 General
Category: CRITICAL CARE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 140 174 $35,670 $11,121
2022 2 126 152 $29,260 $9,559
2021 3 135 153 $29,165 $11,196
2020 3 175 206 $37,720 $12,581
Total Patients
576
Total Services
685
Medicare Billing
$44,457
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 129 160 $32,800 $9,915 30.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 11 14 $2,870 $1,206 42.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 76 93 $19,065 $6,193 32.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 16 21 $4,305 $1,594 37.0%
99443 Telephone medical discussion with physician, 21-30 minutes Facility 2022 22 26 $4,030 $1,131 28.1%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 12 12 $1,860 $641.89 34.5%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 46 49 $10,045 $3,300 32.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 31 38 $7,790 $2,961 38.0%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2021 33 41 $6,005 $2,545 42.4%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 13 13 $3,640 $1,620 44.5%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 12 12 $1,685 $769.93 45.7%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Facility 2020 56 71 $8,670 $3,963 45.7%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 43 49 $13,720 $2,873 20.9%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 25 28 $3,440 $2,223 64.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 24 30 $6,150 $2,071 33.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 27 28 $5,740 $1,451 25.3%

About Allison Pullen, CRNP

Allison Pullen, CRNP is a Nurse Practitioner healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2016. The National Provider Identifier (NPI) number assigned to this provider is 1477915742.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Allison Pullen, CRNP has received a total of $2,144 in payments from pharmaceutical and medical device companies, with $1,162 received in 2024. These payments were reported across 77 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,144).

As a Medicare-enrolled provider, Pullen has provided services to 576 Medicare beneficiaries, totaling 685 services with total Medicare billing of $44,457. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Baltimore, MD
  • Active Since 03/24/2016
  • Last Updated 07/21/2022
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1477915742

Products in Payments

  • XIFAXAN (Drug) $292.62
  • TERLIVAZ (Drug) $272.25
  • RESMETIROM (Drug) $236.02
  • Epclusa (Drug) $92.16
  • IQIRVO (Drug) $83.70
  • OCALIVA (Drug) $72.23
  • MAVYRET (Drug) $63.08
  • FARXIGA (Drug) $62.97
  • TheraSphere Y90 Glass Microspheres 10 GBq (Device) $44.10
  • HYRIMOZ (Biological) $31.65
  • LINZESS (Drug) $26.03
  • VOQUEZNA (Drug) $24.08
  • GORE CARDIOFORM Septal Occluder (Device) $17.65
  • VIBERZI (Drug) $17.07

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Baltimore